Fang Wu

1.1k total citations
42 papers, 803 citations indexed

About

Fang Wu is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Neurology. According to data from OpenAlex, Fang Wu has authored 42 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 13 papers in Epidemiology and 6 papers in Neurology. Recurrent topics in Fang Wu's work include Cerebrovascular and Carotid Artery Diseases (12 papers), Acute Ischemic Stroke Management (8 papers) and Intracranial Aneurysms: Treatment and Complications (5 papers). Fang Wu is often cited by papers focused on Cerebrovascular and Carotid Artery Diseases (12 papers), Acute Ischemic Stroke Management (8 papers) and Intracranial Aneurysms: Treatment and Complications (5 papers). Fang Wu collaborates with scholars based in China, United States and Japan. Fang Wu's co-authors include Régine Romi‐Lebrun, Pierre Escoubas, Terumi Nakajima, Qi Yang, Zhaoyang Fan, Miki Hisada, Marie‐France Martin‐Eauclaire, Bruno Lebrun, Debiao Li and Lan Tang and has published in prestigious journals such as Biochemistry, Stroke and FEBS Letters.

In The Last Decade

Fang Wu

37 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fang Wu China 16 268 236 233 165 119 42 803
Xiangyu Chen China 20 84 0.3× 104 0.4× 293 1.3× 88 0.5× 48 0.4× 115 1.2k
Yasuko Sato Japan 20 216 0.8× 157 0.7× 298 1.3× 36 0.2× 51 0.4× 76 1.1k
Keiko Tanaka Japan 16 59 0.2× 174 0.7× 269 1.2× 49 0.3× 49 0.4× 61 795
John Chi Wang Ho Hong Kong 10 90 0.3× 145 0.6× 306 1.3× 147 0.9× 190 1.6× 17 1.2k
Man Chun Cheung Hong Kong 7 76 0.3× 140 0.6× 185 0.8× 47 0.3× 199 1.7× 10 1.1k
Ahmed Yaqinuddin Saudi Arabia 23 87 0.3× 81 0.3× 533 2.3× 54 0.3× 101 0.8× 98 1.5k
Andy Goren United States 22 59 0.2× 114 0.5× 118 0.5× 64 0.4× 126 1.1× 82 1.5k
Daniel Schnepf Germany 13 91 0.3× 264 1.1× 498 2.1× 31 0.2× 66 0.6× 20 1.3k
Shu Wan China 12 101 0.4× 106 0.4× 247 1.1× 30 0.2× 135 1.1× 38 901
Xiaoqi Wang China 15 77 0.3× 91 0.4× 352 1.5× 57 0.3× 24 0.2× 58 1.0k

Countries citing papers authored by Fang Wu

Since Specialization
Citations

This map shows the geographic impact of Fang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Wu more than expected).

Fields of papers citing papers by Fang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Wu. The network helps show where Fang Wu may publish in the future.

Co-authorship network of co-authors of Fang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Fang Wu. A scholar is included among the top collaborators of Fang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang Wu. Fang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Fang, Siliang Wang, Xihui Xu, et al.. (2025). Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database. Frontiers in Pharmacology. 16. 1459067–1459067. 1 indexed citations
2.
Zhu, Hong, Lü Jin, Fang Wu, et al.. (2025). Population pharmacokinetics of imipenem and target attainment of pharmacokinetic/pharmacodynamic indices in Chinese adults with febrile neutropenia and hematological malignancies. International Journal of Clinical Pharmacy. 47(6). 1920–1932. 1 indexed citations
3.
Wu, Fang, et al.. (2024). Microenvironment-responsive nanosystems for ischemic stroke therapy. Theranostics. 14(14). 5571–5595. 18 indexed citations
4.
Zhou, Jie, Jinping Zhang, Qiaoyun Wang, et al.. (2024). A disproportionality analysis for assessing the safety of FLT3 inhibitors using the FDA Adverse Event Reporting System (FAERS). Therapeutic Advances in Drug Safety. 15. 1591736329–1591736329.
7.
Wu, Fang, et al.. (2023). Temporal-Spatial Evolution and Trend Prediction of the Supply Efficiency of Primary Medical Health Service—An Empirical Study Based on Central and Western Regions of China. International Journal of Environmental Research and Public Health. 20(3). 1664–1664. 4 indexed citations
8.
Zhang, Qian, Gary Rajah, Wenbo Zhao, et al.. (2022). Daily Remote Ischemic Conditioning Can Improve Cerebral Perfusion and Slow Arterial Progression of Adult Moyamoya Disease—A Randomized Controlled Study. Frontiers in Neurology. 12. 811854–811854. 9 indexed citations
9.
Xiao, Jiayu, Tao Jiang, Shuang Xia, et al.. (2021). Acute ischemic stroke versus transient ischemic attack: Differential plaque morphological features in symptomatic intracranial atherosclerotic lesions. Atherosclerosis. 319. 72–78. 21 indexed citations
10.
Wang, Chaoyue, Yue Zhang, Jingwen Du, et al.. (2020). Quantitative Susceptibility Mapping for Characterization of Intraplaque Hemorrhage and Calcification in Carotid Atherosclerotic Disease. Journal of Magnetic Resonance Imaging. 52(2). 534–541. 12 indexed citations
11.
Zhu, Yue, Bin Yang, & Fang Wu. (2020). Understanding of COVID-19 in children from different perspectives of traditional Chinese medicine and western medicine. Zhongcaoyao. 51(4). 6 indexed citations
12.
Zhang, Ling, Shiping Wang, Jing Shen, et al.. (2020). The mental health of Chinese healthcare staff in non-epicenter of COVID-19: a cross-sectional study. Annals of Palliative Medicine. 9(6). 4127–4136. 9 indexed citations
13.
Wu, Fang, Yujiao Yang, Zhaoyang Fan, et al.. (2018). Quantitative assessment of symptomatic intracranial atherosclerosis and lenticulostriate arteries in recent stroke patients using whole-brain high-resolution cardiovascular magnetic resonance imaging. Journal of Cardiovascular Magnetic Resonance. 20(1). 35–35. 26 indexed citations
14.
Wu, Fang, Qingfeng Ma, Haiqing Song, et al.. (2018). Differential Features of Culprit Intracranial Atherosclerotic Lesions: A Whole‐Brain Vessel Wall Imaging Study in Patients With Acute Ischemic Stroke. Journal of the American Heart Association. 7(15). 61 indexed citations
15.
Zhang, Zihao, Zhaoyang Fan, Jiayu Xiao, et al.. (2018). Visualization of the lenticulostriate arteries at 3T using black-blood T1-weighted intracranial vessel wall imaging: comparison with 7T TOF-MRA. European Radiology. 29(3). 1452–1459. 42 indexed citations
16.
Zhang, Xuemin, Wenyu Hu, Feng Feng, Jian Xu, & Fang Wu. (2016). Apelin-13 protects against myocardial infarction-induced myocardial fibrosis. Molecular Medicine Reports. 13(6). 5262–5268. 31 indexed citations
17.
Wu, Fang, et al.. (2013). A Rare Case of Acyclovir-Induced Thrombocytopenia. American Journal of Therapeutics. 21(5). e159–e162. 6 indexed citations
18.
Wu, Fang & Chao Zou. (2007). Childhood Weber–Christian disease: clinical investigation and virus detection. Acta Paediatrica. 96(11). 1665–1669. 8 indexed citations
19.
Escoubas, Pierre, M. Stankiewicz, T Takaoka, et al.. (2000). Sequence and electrophysiological characterization of two insect‐selective excitatory toxins from the venom of the Chinese scorpion Buthus martensi. FEBS Letters. 483(2-3). 175–180. 18 indexed citations
20.
Romi‐Lebrun, Régine, Marie‐France Martin‐Eauclaire, Pierre Escoubas, et al.. (1997). Characterization of Four Toxins from Buthus Martensi Scorpion Venom, which Act on Apamin‐Sensitive Ca2+‐Activated K+ Channels. European Journal of Biochemistry. 245(2). 457–464. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026